About Avallano
Avallano is a company based in Greenville (United States) founded in 2019 by Dean Rogers and Paul Della Maggiora. Avallano has raised $200 thousand across 2 funding rounds from investors including SCRA. Avallano offers products and services including Clinical Research Platform and Patient Engagement App. Avallano operates in a competitive market with competitors including IQVIA, Mural Health, uMotif, Grove AI and Longboat, among others.
- Headquarter Greenville, United States
- Founders Dean Rogers, Paul Della Maggiora
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
-$467.76 K (USD)-331as on Dec 31, 2020
-
EBITDA
Not available
-
Total Equity Funding
$200 K (USD)
in 2 rounds
-
Latest Funding Round
$200 K (USD), Seed
Feb 02, 2021
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Avallano
Avallano offers a comprehensive portfolio of products and services, including Clinical Research Platform and Patient Engagement App.
AI tool for streamlining clinical trials and patient matching.
App for educating and engaging patients in clinical trials.
People of Avallano
Unlock access to complete
Unlock access to complete
Funding Insights of Avallano
Avallano has successfully raised a total of $200K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $200 thousand completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Avallano
Avallano has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include SCRA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startups are accelerated across sectors by SCRA.
|
Locked | Locked | Locked |
Investor details for Avallano
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Avallano
Investment portfolio details for Avallano
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Avallano
Detailed financials for Avallano
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Avallano Comparisons
Peer comparison for Avallano
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Avallano
Avallano operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as IQVIA, Mural Health, uMotif, Grove AI and Longboat, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Clinical research and commercialization solutions are provided for healthcare.
|
|
| Locked | Locked | Locked |
Clinical trial technology platform is provided for participants' streamlined experiences.
|
|
| Locked | Locked | Locked |
Cloud-based application for patient engagement and care coordination
|
|
| Locked | Locked | Locked |
AI powered platform offering clinical trial management solutions
|
|
| Locked | Locked | Locked |
Clinical trial platfoms for sites as well as patients
|
Detailed competitors of Avallano
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Avallano
Complete news archive for Avallano
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avallano
Avallano was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Avallano is headquartered in Greenville, United States.
Paul Della Maggiora is the current CEO of Avallano. They have also founded this company.
Avallano is a funded company, having raised a total of $200K across 2 funding rounds to date.
Avallano was founded in 2019 in Greenville, United States, within the health technology sector. A platform focused on clinical trial patient engagement is operated by the company. AI-driven insights and real-world data collection are integrated to support post-trial interactions. Clinical processes are streamlined through tools for recruitment and protocol document access, serving clients in research and development.
Avallano's top competitors include IQVIA, Mural Health and uMotif.
Avallano offers Clinical Research Platform and Patient Engagement App.
Avallano has 1 investor. Key investors include SCRA.